Effects of A2BR on the biological behavior of mouse renal fibroblasts during hypoxia

Tang,Jin; Jiang,Xianzhen; Zhou,Yihong; Dai,Yingbo

doi:10.3892/mmr.2015.3320

Effects of A2BR on the biological behavior of mouse renal fibroblasts during hypoxia

Authors:
- Jin Tang
- Xianzhen Jiang
- Yihong Zhou
- Yingbo Dai
View Affiliations

Affiliations: Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China
Published online on: February 9, 2015 https://doi.org/10.3892/mmr.2015.3320
Pages: 4397-4402

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Fibroblasts are the effector cells of collagen secretion in renal interstitial fibrosis (RIF), and their proliferation and activation are essential for the development of RIF. Hypoxic ischemia in local tissues has been identified in chronic kidney diseases (CKDs), with adenosine (ADO) as a key signaling molecule. The current study investigated the association between ADO and the biological behavior of renal fibroblasts by establishing an in vitro hypoxia cell model. This aimed to provide experimental evidence for the prevention and treatment of RIF. NIH3T3 fibroblasts were exposed to hypoxia, and the subtypes of the ADO receptor (AR) on the cell surface were identified by a TaqMan probe‑based assay. Cells were divided into the following four groups: i) Control; ii) 5'‑N‑ethylcarboxamidoadenosine (NECA); iii) PT, NECA + 8‑phenyltheophylline (PT); and iv) MRS, NECA + N‑(4‑cyanophenyl)‑2‑[4‑(2,3,6,7‑tetrahydro‑2,6‑dioxo‑1,3‑dipropyl‑1H‑purin‑8‑yl)phenoxy]‑acetamide (MRS1754). The mRNA levels of transforming growth factor‑β1 (TGF‑β1), procollagen α1 (I) and α‑smooth muscle actin (α‑SMA) were measured following 24, 48, and 72 h of hypoxia. Cell proliferation was evaluated by a 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay at 0, 12, 24, 48 and 72 h. The results demonstrated that A2BR was the predominant AR subtype present in hypoxia‑stimulated fibroblasts. NECA significantly induced fibroblast proliferation and upregulated the expression of TGF‑β1, procollagen α1 (I) and α‑SMA mRNA, while 8‑PT and MRS1754 inhibited fibroblast proliferation and downregulated the expression of TGF‑β1, procollagen α1 (I) and α‑SMA mRNA. The blockage of A2BR in hypoxia significantly inhibited the proliferation and activation of fibroblasts, and reduced the production of profibrotic cytokines, thus preventing the generation and development of fibrosis.

View Figures

View References

1	Noronha IL, Fujihara CK and Zatz R: The inflammatory component in progressive renal disease - are interventions possible? Nephrol Dial Transplant. 17:363–368. 2002. View Article : Google Scholar : PubMed/NCBI
2	Badid C, Vincent M, Fouque D, Laville M and Desmoulière A: Myofibroblast: A prognostic marker and target cell in progressive renal disease. Ren Fail. 23:543–549. 2001. View Article : Google Scholar : PubMed/NCBI
3	Roberts IS, Burrows C, Shanks JH, Venning M and McWilliam LJ: Interstitial myofibroblasts: Predictors of progression in membranous nephropathy. J Clin Pathol. 50:123–127. 1997. View Article : Google Scholar : PubMed/NCBI
4	Razzaque MS and Taguchi T: Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc. 35:68–80. 2002. View Article : Google Scholar : PubMed/NCBI
5	Zeisberg M, Strutz F and Müller GA: Renal fibrosis: An update. Curr Opin Nephrol Hypertens. 10:315–320. 2001. View Article : Google Scholar : PubMed/NCBI
6	Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol. 15:290–301. 2000. View Article : Google Scholar
7	Fredholm BB: Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14:1315–1323. 2007. View Article : Google Scholar : PubMed/NCBI
8	Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC and Colgan SP: Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: Coordination by extracellular nucleotide metabolism. Blood. 104:3986–3992. 2004. View Article : Google Scholar : PubMed/NCBI
9	Tang J, Jiang X, Zhou Y, Xia B and Dai Y: Increased adenosine levels contribute to ischemic kidney fibrosis in the unilateral ureteral obstruction model. Exp Ther Med. 9:737–743. 2015.PubMed/NCBI
10	Chunn JL, Mohsenin A, Young HW, Lee CG, Elias JA, Kellems RE and Blackburn MR: Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am J Physiol Lung Cell Mol Physiol. 290:L579–L587. 2006. View Article : Google Scholar
11	Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE and Blackburn MR: Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol. 175:1937–1946. 2005. View Article : Google Scholar : PubMed/NCBI
12	Chunn JL, Young HW, Banerjee SK, Colasurdo GN and Blackburn MR: Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol. 167:4676–4685. 2001. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Strutz F and Zeisberg M: Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol. 17:2992–2998. 2006. View Article : Google Scholar : PubMed/NCBI
15	Chen CZ and Raghunath M: Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art. Fibrogenesis Tissue Repair. 2:72007. View Article : Google Scholar
16	Blackburn MR, Volmer JB, Thrasher JL, Zhong H, Crosby JR, Lee JJ and Kellems RE: Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med. 192:159–170. 2000. View Article : Google Scholar : PubMed/NCBI
17	Linden J: Adenosine in tissue protection and tissue regeneration. Mol Pharmacol. 67:1385–1387. 2005. View Article : Google Scholar : PubMed/NCBI
18	Van Belle H, Goossens F and Wynants J: Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am J Physiol. 252:H886–H893. 1987.PubMed/NCBI
19	Rego AC, Santos MS and Oliveira CR: Adenosine triphosphate degradation products after oxidative stress and metabolic dysfunction in cultured retinal cells. J Neurochem. 69:1228–1235. 1997. View Article : Google Scholar : PubMed/NCBI
20	Wei CJ, Li W and Chen JF: Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim Biophys Acta. 1808:1358–1379. 2011. View Article : Google Scholar
21	Mi T, Abbasi S, Zhang H, et al: Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest. 118:1491–1501. 2008. View Article : Google Scholar : PubMed/NCBI
22	Rudolphi KA, Schubert P, Parkinson FE and Fredholm BB: Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev. 4:346–369. 1992.PubMed/NCBI
23	Schubert P, Rudolphi KA, Fredholm BB and Nakamura Y: Modulation of nerve and glial function by adenosine - role in the development of ischemic damage. Int J Biochem. 26:1227–1236. 1994. View Article : Google Scholar : PubMed/NCBI
24	Zhu JF, Tang LM and Li DC: Activation of adenosine 2A receptor attenuating oxidative stress on small-for-size liver transplantation. Chin J Bases And Clin In Gen Surg. 17:243–247. 2010.
25	Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K and Eltzschig HK: The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5:e1372008. View Article : Google Scholar : PubMed/NCBI
26	Lu Q, Sakhatskyy P, Newton J, et al: Sustained adenosine exposure causes lung endothelial apoptosis: a possible contributor to cigarette smoke-induced endothelial apoptosis and lung injury. Am J Physiol Lung Cell Mol Physiol. 304:L361–L370. 2013. View Article : Google Scholar : PubMed/NCBI
27	Yap SC and Lee HT: Adenosine and protection from acute kidney injury. Curr Opin Nephrol Hypertens. 21:24–32. 2012. View Article : Google Scholar :
28	Mubagwa K and Flameng W: Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res. 52:25–39. 2001. View Article : Google Scholar : PubMed/NCBI
29	Leask A: Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment. Fibrogenesis Tissue Repair. 3:82010. View Article : Google Scholar : PubMed/NCBI
30	Malmström J, Lindberg H, Lindberg C, et al: Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics. 3:466–477. 2004. View Article : Google Scholar : PubMed/NCBI
31	Ohtaka A, Ootaka T, Sato H and Ito S: Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: Developmental paradigm. Nephrol Dial Transplant. 17(Suppl 9): 11–15. 2002. View Article : Google Scholar
32	Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC and Lan HY: Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis. 38:761–769. 2001. View Article : Google Scholar : PubMed/NCBI
33	Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K and Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest. 87:847–858. 1991. View Article : Google Scholar : PubMed/NCBI
34	Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ, Yang WC, Huang TP, Atkins RC and Lan HY: Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant. 14:2860–2872. 1999. View Article : Google Scholar : PubMed/NCBI
35	Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol. 7:2495–2508. 1996.PubMed/NCBI
36	Zhang G, Moorhead PJ and el Nahas AM: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol. 3:308–318. 1995.PubMed/NCBI
37	Hewitson TD, Wu HL and Becker GJ: Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol. 15:411–417. 1995. View Article : Google Scholar : PubMed/NCBI
38	Ling H, Li X, Jha S, Wang W, Karetskaya L, Pratt B and Ledbetter S: Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: Morphologic improvement associated with functional preservation. J Am Soc Nephrol. 14:377–388. 2003. View Article : Google Scholar : PubMed/NCBI